For the Inventor, By the Inventor

Enter assignee name

Université Paris—sud

USPTO Granted Patents = 99

CIPO Patents = 11

EPO Patents = 85

Forward Citations = 169

Loading Chart...

Loading Chart...

311 inventors (with patents filed for the assignee):

William Vainchenker (9 out of 13 patents)

Nicole Casadevall (6 out of 7 patents)

Jean-Pierre Le Couedic (5 out of 6 patents)

4. Olivier Christophe (4 out of 11 patents)

5. Jean-Daniel Brion (4 out of 15 patents)

6. Eli Hatchwell (3 out of 35 patents)

7. Peggy S Eis (3 out of 34 patents)

8. Sylvia Cohen-Kaminsky (3 out of 5 patents)

9. Gilles Bru-Mercier (3 out of 5 patents)

10. Mouad Alami (3 out of 11 patents)

11. Samir Messaoudi (3 out of 6 patents)

12. Jamila Faivre (3 out of 3 patents)

13. Franck Viguie (3 out of 4 patents)

14. Olivier Bernard (3 out of 8 patents)

15. Michaela Fontenay (3 out of 6 patents)

Core Competencies:

Lymphoid Progenitors

Heads-Up Display

Antibodies

Polypeptides

Dizocilpine Derivatives

Minibeam Radiotherapy

JAK2 Mutation

Electrochemical Detection

3D Printing

Cytotoxic Compounds

Microfluidic Analysis

Antiviral Agents

99 patents: Sort by Forward Citations

1. 12129487 - Method to obtain lymphoid progenitors (2024-10-29),

2. 12105254 - Element for covering the projection aperture of a heads-up display device (2024-10-01),

3. 11597777 - Antibodies for the prevention or the treatment of bleeding episodes (2023-03-07),

4. 11484569 - Polypeptide for use in the protection of oxygen sensitive gram-positive bacteria (2022-11-01),

5. 11376245 - Dizocilpine derivatives as peripheral NMDA receptor antagonists (2022-07-05),

6. 11285133 - 2- or 3-imidazolines as carbapenemases inhibitors (2022-03-29),

7. 11235174 - Minibeam radiotherapy device (2022-02-01),

8. 11221341 - Process for in vitro diagnosis of hepatic disorders (2022-01-11),

9. 11203788 - TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms (2021-12-21),

10. 11162100 - Identification of a JAK2 mutation in polycythemia vera (2021-11-02),

11. 11085921 - Electronic nose or tongue sensors (2021-08-10),

12. 11046657 - Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines (2021-06-29),

13. 11014871 - 'Multi-target' compounds with inhibitory activity towards histone deacetylases and tubulin polymerisation, for use in the treatment of cancer (2021-05-25),

14. 10955654 - Imaging device and method (2021-03-23),

15. 10895551 - System for electrochemical detection of molecules of interest (2021-01-19),

Université Paris-Sud, located in Orsay, France, is one of the leading research universities in the country. Established in 1970, it offers a wide range of programs in science, technology, health, and social sciences. The university is known for its strong emphasis on research and innovation, hosting numerous laboratories and research centers. It is part of the Paris-Saclay University, which aims to foster collaboration among academic institutions and industries. With a diverse student body and a commitment to academic excellence, Université Paris-Sud plays a significant role in the higher education landscape in France and beyond.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

99 Patents

#1 in Orsay

#264 in France

#7,614 in the World

Université Paris—sud

Forward Citations = 169

311 inventors:

William Vainchenker (9 out of 13 patents)

Nicole Casadevall (6 out of 7 patents)

Jean-Pierre Le Couedic (5 out of 6 patents)

4. Olivier Christophe (4 out of 11 patents)

5. Jean-Daniel Brion (4 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…